Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans
Clinical trial NCT00541866 · COMPLETED
Trial details
- NCT number
- NCT00541866
- Sponsor
- Sunesis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-06
- Primary completion
- 2012-02-15
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.